Indoco Remedies declines on reporting 36% fall in Q4 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Indoco Remedies is currently trading at Rs. 338.95, down by 3.50 points or 1.02% from its previous closing of Rs. 342.45 on the BSE.
The scrip opened at Rs. 330.05 and has touched a high and low of Rs. 343.60 and Rs. 329.95 respectively. So far 12296 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 423.10 on 02-Jan-2023 and a 52 week low of Rs. 307.00 on 26-Apr-2023.
Last one week high and low of the scrip stood at Rs. 362.95 and Rs. 331.95 respectively. The current market cap of the company is Rs. 3123.44 crore.
The promoters holding in the company stood at 58.69%, while Institutions and Non-Institutions held 19.60% and 21.70% respectively.
Indoco Remedies has reported results for fourth quarter (Q4) and year ended March 31, 2023.
The company has reported 37.16% fall in net profit at Rs 25.37 crore for the quarter under review as compared to Rs 40.37 crore for the same quarter in the previous year. However, total income of the company increased by 4.59% at Rs 427.95 crore for Q4FY23 as compared to Rs 409.17 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 36.19% fall in its net profit at Rs 25.81 crore for fourth quarter ended March 31, 2023 as compared to Rs 40.45 crore for the same quarter in the previous year. However, total income of the company increased by 4.70% at Rs 428.66 crore for Q4FY23 as compared to Rs 409.43 crore for the corresponding quarter previous year.
For the year ended March 31, 2023, the company has reported 8.52% fall in its net profit at Rs 141.36 crore as compared to Rs 154.52 crore for the previous year. However, total income of the company increased by 8.23% at Rs 1669.02 crore for year under review as compared to Rs 1542.04 crore for year ended March 31, 2022.
For the year ended March 31, 2023, on the consolidated basis, the company has reported 8.11% fall in its net profit at Rs 142.25 crore as compared to Rs 154.80 crore for the previous year. However, total income of the company increased by 8.29% at Rs 1670.95 crore for year under review as compared to Rs 1543.08 crore for year ended March 31, 2022.
